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CASEREPORT 
A 29-year-old patient with AIDS was admitted with a 
3-week history of headache and a 1-week history of 
nausea. The patient was taking stavudine, dapsone and 
pyrimethamine for prophylaxis, ganciclovir for cyto- 
megalovirus (CMV) retinitis, and cortisone for adrenal 
failure. The clinical examination revealed nuchal 
rigidity and a temperature of 39°C. Apart from this, 
neurologic status was normal. There were no other 
clinical pathologic findings except for the known 
Kaposi's sarcoma lesions, and the patient had no 
pulmonary complaints, cough or sputum. The central 
nervous system (CNS) CT scan, performed im- 
mediately, was normal. A lumbar puncture showed clear 
cerebrospinal fluid (CSF) with 30 mm H20 opening 
pressure and 1.08 g/L proteins. Cytology revealed 19 
leukocytes/mL (polymorphonuclear 50%, lymphocytes 
47%, monocytes 21%, basophils 1% and eosinophils 
1%). There were no organisms on direct examination 
and the bacterial and fungal cultures were sterile. 
Cryptococcal antigen was negative in CSF and in blood. 
Serology for toxoplasmosis was negative. The patient 
was treated with ceftriaxone. Four days later, the patient 
developed a left motor hemisyndrome with anisocoria. 
A second CT scan showed a right pediculothalamic 
hypodensity. The CNS MRI showed meningeal axial 
and cranial enhancement after gadolinium injection 
in T1-weighted images of the interpeduncular opto- 
chiasmatic cisterns. T2-weighted axial images also 
showed hyperintensity of the medulla oblongata, the 
right peduncle and the right tectum, without contrast 
enhancement. The radiologic diagnosis was of basal 
cistern meningitis with bulbar-peduncular encephalitis. 
There was also a thickened left maxillary and right 
sphenoid sinus wall without fluid. Chest radiographs 
and the abdominal CT scan were normal. 
Another lumbar puncture showed clear CSF, 
1.58 g/L proteins; 2 erythrocytes/mL and 83 leuko- 
cytes/mL (83% polymorphonuclear, 4% lymphocytes, 
13% monocytes). Again, there were no organisms on 
Gram-stain direct examination. Polymerase chain 
reaction performed in the CSF for JC virus, CMV, 
Epstein-Barr virus and mycobacteria were all negative. 
Fungal cultures were also negative after 3 months for 
both CSF samples. Apart from one blood culture which 
was positive for Mycobacteriurn aviurn, all other blood 
cultures were negative. Serology in CSF showed posi- 
tive VDRL, but FTA and TPHA were both negative, 
and blood VDRL, FTA and TPHA were all negative. 
Two days later, the patient died in a comatose state. 
Autopsy was performed 26 h after death. At extraction 
of the brain, a purulent exudate was noted in the 
subarachnoid space around the pons, the chiasma and 
diaphragma sellae. In addition to purulent basilar 
meningitis, macroscopic analysis revealed thrombosis of 
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a few branches of the basilar artery, as well as pontine 
and right thalamic infarcts. 
The main histologic finding was the presence of 
massive quantities of dichotomously branched, Grocott- 
positive hyphae, morphologically typical of Aspergiffus 
spp., within the purulent subarachnoid collections. 
These microorganisms had crossed the diaphragma 
sellae without infiltrating the pituitary parenchyma. 
The same exudate was seen at the medial aspect of the 
anterior temporal lobe and the ventral aspect of the 
pons (Figure 1). Certain branches of the basilar artery 
showed vasculitis with hyphae invading the vessel wall 
and fresh thrombosis (Figure 2) .  The diagnosis was of 
aspergillus meningoencephalitis. 
The autopsy also revealed bilateral foci of bacterial 
bronchopneumonia without any fungal microorgan- 
ism. No Aspergiffus organisms were found. There were 
also thoracic lymph nodes containing macrophages 
laden with acid-fast bacdli. No other foci of asper- 
gillosis were detected outside the CNS, despite careful 
investigation. 
REVIEW OF THE LITERATURE AND DISCUSSION 
We have reported here a case of primary CNS 
aspergdlosis in an AIDS patient. Despite extensive 
clinical investigation and careful autopsy, no other focus 
of aspergdlosis was identified; in particular, the chest 
radiographs were normal and no fungi were present in 
lung autopsy. To our knowledge, only five cases of 
primary aspergdlosis have been described in the 
literature, and we report the first case of basal meningo- 
encephalitis in an AIDS patient. Beside tuberculosis, 
CMV, syphilis and others, aspergillosis should be added 
to the differential diagnosis of basal meningitis in AIDS. 
When the CNS is infected, Aspergillus is spread by 
the hematogenous route from the primary site of 
infection, which is usually the lungs or, less commonly, 
by direct extension from an infected sinus [1-4]. 
Aspergillus meningitis has been described in patients 
where the route of entry was a central venous catheter, 
and in drug users as a result of bloodstream injections 
[5-6,9]. In our patient, the central catheter was clean. 
Figure 1 Exudate of pre-pontine subarachnoid space occupied by massive quantities of 
hyphae. HE X63. 
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Direct Aspergillus inoculation after surgical procedures 
or trauma has also been reported [7,8]. 
The most frequent lesions observed in CNS 
aspergillosis are subcortical hemorrhagic or ischemic 
infarcts due to fungal thrombosis [3,1 @-I 21. Aspergillus 
meningitis is mainly restricted to the base of the brain 
and can be associated with abscesses in the brain or in 
the spinal cord [13-161. Granulomatous formation is 
rare, and is generally seen in patients who have had 
systemic aspergillosis over a long period of time [17]. 
Diagnosis of CNS aspergillosis is very difficult to 
make and, in most reports, is made either at a late stage 
in the disease or at autopsy. CSF cultures have only 
rarely been reported as positive [2,3,10,11,18,19]. In 
cases reported of patients diagnosed before death with 
CNS aspergillosis, only biopsy provided the diagnosis 
[3,7,10,20]. In our patient, the CSF cultures were 
sterile. 
To our knowledge, CNS aspergillosis has only 
been described on five occasions as a primary CNS 
infection locus without other proven foci of infection 
[ 18,191. 
The first case was a spinal arachnoiditis due to 
aspergillus meningitis in a previously healthy patient. 
The diagnosis was made by biopsy and the patient was 
successfully treated with amphotericin B [ 191. 
In another case, an AIDS patient, with a brain 
abscess due to Aspergillus Javus, was diagnosed at 
autopsy without any fungus being present at other body 
sites, despite suspected hemorrhagic intra-alveolar lung 
lesions. Special stains for microorganisms were negative 
in the lung [ 181. 
In an autopsy review of 26 cases of CNS asper- 
gillosis, three patients had an undetermined site of 
origin for the infection at autopsy. However, clinical, 
radiologic and pathologic examinations are not 
individually described [3]. 
CT scan is neither sufficiently sensitive nor specific 
to confirm the diagnosis of CNS aspergillosis [2,10] 
and, as in our case, MRI should therefore be per- 
formed. When a case of CNS aspergillosis cannot be 
explained by the evidence of systemic aspergillosis, 
sinuses may have been the portals of entry [3,10- 
123-241. In our patient, the sphenoid sinus was 
Figure 2 Fresh thrombosis of a meningeal artery showing intraluminal fibrinous network. 
PTAH X160. 
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examined at autopsy, and no fungus or sinusitis were 
present. In addition, MRI showed no signs of d a r y  
or ethmoidal sinusitis. In many series, aspergillus 
meningitis is inexorably associated with death despite 
antifungal therapy [3,17,19,25-271. At present, ampho- 
tericin B or high-dose itraconazole are the first choices 
for treatment, but there is hope for a better response 
with forthcoming new agents such as voriconazole or 
the new intravenous formulation for itraconazole. 
Addition of flucytosine to the regimen should be 
considered. 
Although the prognosis of cerebral aspergillosis is 
very poor, it has been shown in the few successhlly 
treated cases [2,28] that only early initiation of therapy 
can cure the disease. 
There is a need for the physician to be aware that 
primary CNS aspergillosis can occur in AIDS. An 
extensive search for fungus, using more sensitive 
methods such as biopsy, PCR [29] or antigen detection 
[30], in all cases of undiagnosed meningoencephalitis 
among patients at risk is necessary. 
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